Dr. Patrice Milos, PhD

Dr. Milos co-founded Medley Genomics to deliver novel data analytics for individualizing treatment of complex diseases with an initial focus in oncology. Immediately prior, Patrice was CEO of Claritas Genomics, a pediatric molecular diagnostic company spin-out from Boston Children’s Hospital. Dr. Milos was Boston Site Head for Pfizer’s Centers of Therapeutic Innovation, establishing academic-medical center partnerships to advance novel therapies to treat human disease. She was also SVP/CSO for Helicos BioSciences in Cambridge, MA, and Executive Director for Pfizer Inc, responsible for leading genomics supporting Pfizer portfolio. Currently, Dr. Milos serves on the Board of Directors for Rhode Island’s BIO Affiliate, the European Commission funded ULTRAPLACAD External Advisory Board and is Senior Advisor to Atlas Genetics and Social Enterprise Greenhouse. Patrice earned her MS/PhD at Rensselaer Polytechnic Institute with postdoctoral fellowships at Brown and Harvard.